Patient-derived organoid models were constructed to assess the therapeutic efficiency of Oxypalmatine in breast cancer.
[Phytomedicine]
Oxypalmatine Regulates Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting PI3K/AKT Signaling and Its Efficacy Against Breast Cancer Organoids
